| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/28/2007 | CN1919172A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919171A Medicinal composition of nimustine and its progression agent |
| 02/28/2007 | CN1919170A Colloid pectin bismuth dry suspensoid and its preparing process |
| 02/28/2007 | CN1919169A Penciclovir emulsifiable paste and its preparation |
| 02/28/2007 | CN1302021C Non-aqueous absorbent and use thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301747C Protein medicine microcapsule and inhalational aerosol thereof |
| 02/28/2007 | CN1301733C Compound medicine for treating diabetes and its preparation process |
| 02/28/2007 | CN1301732C Paste for epidemic diarrhea and method for preparing the same |
| 02/28/2007 | CN1301730C Medicine for treating decayed tooth and toothache |
| 02/28/2007 | CN1301728C Chinese medicine compound preparation for treating osteoarthropathy and its preparation method |
| 02/28/2007 | CN1301726C Chinese medicinal capsule for treating asthenic cold type prolonged diarrhea |
| 02/28/2007 | CN1301725C Wasting-thirst capsule of root powder for treating diabetes |
| 02/28/2007 | CN1301718C Extraction for radix cynanchi bungei polysaccharide and oral lozenge preparation |
| 02/28/2007 | CN1301716C Slow-releasing Benproperine phosphate dripping pill and its prepn process |
| 02/28/2007 | CN1301713C Stephanine soft capsule, and its preparation method |
| 02/28/2007 | CN1301709C Skin plaster containing aceclofenac |
| 02/28/2007 | CN1301707C Danhong freeze dried powder injection agent and its preparation method |
| 02/28/2007 | CN1301706C Pharmaceutical composition for sustained or continuous releasing therapeutic active components |
| 02/27/2007 | USRE39497 Storage of materials |
| 02/27/2007 | US7183337 Films with optical clarity, wear resistance and superior performance with nanofillers and polymers for thin films |
| 02/27/2007 | US7183321 Antidiabetic formulation and method |
| 02/27/2007 | US7183272 Crystal forms of oxcarbazepine and processes for their preparation |
| 02/27/2007 | US7183265 Powdery product comprising crystalline β-maltose monohydrate, its preparation, and uses |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7182965 pollen polyterpenes for the treatment of microbial, especially bacterial, diseases for topical, oral and parenteral administration in humans and animals |
| 02/27/2007 | US7182964 Dissolving thin film xanthone supplement |
| 02/27/2007 | US7182963 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 02/27/2007 | US7182961 Particulate compositions for pulmonary delivery |
| 02/27/2007 | US7182960 Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
| 02/27/2007 | US7182959 Preparing powder consisting of active substance and all other ingredients of solid dosage form, dispensing solvent solution or dispersion in mold, putting compacted powder on top of liquid in mold, desolventizing |
| 02/27/2007 | US7182958 With oral bioavailability; tadalafil; erectile dysfunction |
| 02/27/2007 | US7182957 Combination of chitosan and second polymer that are not covalently or ionically crosslinked, prepared by dissolving both polymers in an acidic aqueous solution, dehydrating and recovering |
| 02/27/2007 | US7182956 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 02/27/2007 | US7182955 Abuse-resistant transdermal dosage form |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/27/2007 | US7182950 Nano-sized self-assembled liquid dilutable vehicles |
| 02/27/2007 | US7182949 Composition comprising vitamin C prepared during application, use of enzymes for forming vitamin C for topical use, and a cosmetic treatment method |
| 02/27/2007 | US7182948 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 02/27/2007 | US7182933 Biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell |
| 02/27/2007 | US7182748 Syringe and capsule therefor |
| 02/27/2007 | US7182199 Systems, methods and apparatuses for manufacturing dosage forms |
| 02/27/2007 | CA2286329C Vaginal tampon and process for producing the same |
| 02/27/2007 | CA2256410C Stable pharmaceutical composition of bdnf |
| 02/27/2007 | CA2240281C Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 02/27/2007 | CA2158689C Medical devices containing triggerable disintegration agents |
| 02/26/2007 | CA2557377A1 Mucosal delivery tablet |
| 02/23/2007 | CA2516968A1 Drug delivery targeting by rod deformation |
| 02/22/2007 | WO2007022356A2 Drug-surfactant complexes for sustained release |
| 02/22/2007 | WO2007022152A2 Lipid nano particulates containing antigens as cancer vaccines |
| 02/22/2007 | WO2007022149A2 Non-woven scaffold for tissue engineering |
| 02/22/2007 | WO2007022140A2 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20 |
| 02/22/2007 | WO2007022105A2 Stable pharmaceutical compositions, processes for making the same, and methods of their use |
| 02/22/2007 | WO2007022090A2 Topical delivery with a carrier fluid |
| 02/22/2007 | WO2007022069A1 Mouth-moistening compositions, delivery systems containing same and methods of making same |
| 02/22/2007 | WO2007022056A2 Sensation masking composition |
| 02/22/2007 | WO2007021968A2 Sustained release antihistamine and decongestant composition |
| 02/22/2007 | WO2007021844A2 Coated substrate with properties of keratinous tissue |
| 02/22/2007 | WO2007021822A2 Compositions and methods of preparation of liposomal microparticulate il-12 |
| 02/22/2007 | WO2007021754A2 Diltiazem controlled release formulation and method of manufacture |
| 02/22/2007 | WO2007021735A2 Use of phospholipid arachidonic acids for increasing muscle mass in humans |
| 02/22/2007 | WO2007021228A1 Process |
| 02/22/2007 | WO2007021189A2 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion |
| 02/22/2007 | WO2007021168A1 Sublingual solid pharmaceutical formulations containing meloxicam |
| 02/22/2007 | WO2007021101A1 Sustained-release pellet formulation of alpha1-receptor antagonist and process for the preparation thereof |
| 02/22/2007 | WO2007021072A1 Metformin tablet with sustained release and method for preparing the same |
| 02/22/2007 | WO2007021033A1 Tablet having multiple drug-containing segments |
| 02/22/2007 | WO2007021032A1 Preparation with accurate dose-dividing function |
| 02/22/2007 | WO2007021020A1 Capsinoid containing composition |
| 02/22/2007 | WO2007021008A1 Process for producing plaster, apparatus for producing the same, and liner for plaster |
| 02/22/2007 | WO2007020893A1 Water-soluble metal alcoholate derivative, process for production of the derivative, and solid gelatinous agent for external application comprising the derivative |
| 02/22/2007 | WO2007020871A1 Technique for stabilization of yw753 reparation |
| 02/22/2007 | WO2007020671A2 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 02/22/2007 | WO2007020529A2 Method for banding hard capsules using hydroxypropylmethyl cellulose (hpmc) as a base |
| 02/22/2007 | WO2007020507A2 Medicinal forms of phospholipid preparations and methods for their preparation |
| 02/22/2007 | WO2007020349A1 Oil-in-water-type emulsion for topical application in dermatology |
| 02/22/2007 | WO2007020262A2 Chocolate coated spherical filled capsules |
| 02/22/2007 | WO2007020260A2 Pancreatin micropellet cores suitable for enteric coating |
| 02/22/2007 | WO2007020259A2 Controlled release pharmaceutical compositions for acid labile drugs |
| 02/22/2007 | WO2007020085A2 Compositions containing taxane derivatives for intravenous injection |
| 02/22/2007 | WO2007019883A1 Chocolate coated spherical filled capsules |
| 02/22/2007 | WO2007019882A1 Seamless coated spherical filled capsules |
| 02/22/2007 | WO2007001451A9 Stabilized hme composition with small drug particles |
| 02/22/2007 | WO2006138202A3 Pharmaceutical formulations for minimizing drug-drug interactions |
| 02/22/2007 | WO2006134279A3 Method for solubilizing metronidazole |
| 02/22/2007 | WO2006127742A3 Indicia bearing package for delivery systems |
| 02/22/2007 | WO2006127618A3 Compressible gum based delivery systems for the release of ingredients |
| 02/22/2007 | WO2006124047A3 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 02/22/2007 | WO2006121742A3 Formulations of a src/abl inhibitor |
| 02/22/2007 | WO2006119389A3 Quinine-containing controlled-release formulations |
| 02/22/2007 | WO2006112744A3 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 02/22/2007 | WO2006110555A9 Cleansing foaming sunscreen lotion |
| 02/22/2007 | WO2006100308A3 Compositions comprising microcapsules consisting of autolysed microbial cells and encapsulated material |
| 02/22/2007 | WO2006099169A3 Novel liposome compositions |
| 02/22/2007 | WO2006081347B1 Controlled release compositions comprising an antipsychotic agent |
| 02/22/2007 | WO2006074398A3 Sustained release pharmaceutical formulations comprising ranolazine |
| 02/22/2007 | WO2006063109A3 Room-temperature stable dronabinol formulations |